>
Fa   |   Ar   |   En
   Effect of arteriovenous anastomosis on blood pressure reduction in patients with isolated systolic hypertension compared with combined hypertension  
   
نویسنده ott c. ,lobo m.d. ,sobotka p.a. ,mahfoud f. ,stanton a. ,cockcroft j. ,sulke n. ,dolan e. ,van der giet m. ,hoyer j. ,furniss s.s. ,foran j.p. ,witkowski a. ,januszewicz a. ,schoors d. ,tsioufis k. ,rensing b.j. ,saxena m. ,scott b. ,ng g.a. ,achenbach s. ,schmieder r.e. ,ott c. ,schmid m. ,achenbach s. ,schmieder r.e. ,jain a. ,knight c. ,lobo m.d. ,mathur a. ,saxena m. ,balmforth p. ,luitjens s.f. ,sobotka p.a. ,smits g. ,mahfoud f. ,stanton a. ,cockcroft j.r. ,sulke n. ,dolan e. ,van dergiet m. ,hoyer j. ,furniss s.s. ,foran j.p. ,mungur d. ,witkowski a. ,januszewicz a. ,prejbisz a. ,kadziela j. ,galvin j. ,schoors d. ,dimitriadis k. ,tsioufis k. ,rensing b.j. ,scott b. ,ng a.
منبع journal of the american heart association - 2016 - دوره : 5 - شماره : 12
چکیده    Background--options for interventional therapy to lower blood pressure (bp) in patients with treatment-resistant hypertension include renal denervation and the creation of an arteriovenous anastomosis using the rox coupler. it has been shown that bp response after renal denervation is greater in patients with combined hypertension (ch) than in patients with isolated systolic hypertension (ish). we analyzed the effect of rox coupler implantation in patients with ch as compared with ish. methods and results--the randomized,controlled,prospective rox control hypertension study included patients with true treatment-resistant hypertension (office systolic bp ≥140 mm hg,average daytime ambulatory bp ≥135/85 mm hg,and treatment with ≥3 antihypertensive drugs including a diuretic). in a post hoc analysis,we stratified patients with ch (n=31) and ish (n=11). baseline office systolic bp (177±18 mm hg versus 169±17 mm hg,p=0.163) and 24-hour ambulatory systolic bp (159±16 mm hg versus 154±11 mm hg,p=0.463) did not differ between patients with ch and those with ish. rox coupler implementation resulted in a significant reduction in office systolic bp (ch: -29±21 mm hg versus ish: -22±31 mm hg,p=0.445) and 24-hour ambulatory systolic bp (ch: -14±20 mm hg versus ish: -13±15 mm hg,p=0.672),without significant differences between the two groups. the responder rate (office systolic bp reduction ≥10 mm hg) after 6 months was not different (ch: 81% versus ish: 82%,p=0.932). conclusions--our data suggest that creation of an arteriovenous anastomosis using the rox coupler system leads to a similar reduction of office and 24-hour ambulatory systolic bp in patients with combined and isolated systolic hypertension. © 2016 the authors.
کلیدواژه Arteriovenous anastomosis; Combined hypertension; Isolated systolic hypertension; Treatment resistant hypertension
آدرس department of nephrology and hypertension,friedrich-alexander university erlangen-nürnberg,erlangen, Germany, friedrich-alexander university erlangen-nürnberg (fau),erlangen,germany,william harvey research institute,barts nihr cardiovascular biomedical research unit,queen mary university of london, United Kingdom, rox medical,san clemente,ca, United States, klinik für innere medizin iii,universitätsklinikum des saarlandes,homburg/saar, Germany, molecular and cellular therapeutics,royal college of surgeons in ireland medical school,dublin, Ireland, cardiolgy department,wales heart research institute,cardiff, United Kingdom, cardiology department,eastbourne district general hospital,east sussex, United Kingdom, department of medicine for the elderly,connolly hospital,dublin, Ireland, department of endocrinology and nephrology,universitätsmedizin berlin,berlin, Germany, department of internal medicine and nephrology,universitätsklinikum gießen und marburg gmbh,marburg, Germany, department of cardiology,east sussex healthcare nhs trust,east sussex, United Kingdom, cardiac department,royal brompton hospital,london,united kingdom,cardiolgy department,st helier hospital,surrey, United Kingdom, institute of cardiology,warsaw, Poland, institute of cardiology,warsaw, Poland, department of cardiology,universitair ziekenhuis brussel,brussels, Belgium, department of cardiology,hippokration general hospital of athens, Greece, department of cardiology,st antonius ziekenhuis,nieuwegein, Netherlands, friedrich-alexander university erlangen-nürnberg (fau),erlangen,germany,william harvey research institute,barts nihr cardiovascular biomedical research unit,queen mary university of london, United Kingdom, department of cardiology,zna - cardio middelheim,antwerp, Belgium, department of cardiovascular sciences,university of leicester glenfield hospital/nihr,leicester cardiovascular biomedical research,leicester, United Kingdom, department of cardiology,friedrich-alexander university erlangen-nürnberg,erlangen,germany,molecular and cellular therapeutics,royal college of surgeons in ireland medical school,dublin, Ireland, department of nephrology and hypertension,friedrich-alexander university erlangen-nürnberg,erlangen, Germany, friedrich-alexander university erlangen- nürnberg,erlangen, Germany, friedrich-alexander university erlangen- nürnberg,erlangen, Germany, friedrich-alexander university erlangen- nürnberg,erlangen, Germany, friedrich-alexander university erlangen- nürnberg,erlangen, Germany, barts nihr cardiovascular biomedical research institute,queen mary university of london,london, United Kingdom, barts nihr cardiovascular biomedical research institute,queen mary university of london,london, United Kingdom, barts nihr cardiovascular biomedical research institute,queen mary university of london,london, United Kingdom, barts nihr cardiovascular biomedical research institute,queen mary university of london,london, United Kingdom, barts nihr cardiovascular biomedical research institute,queen mary university of london,london, United Kingdom, rox medical inc,san clemente,ca, United States, rox medical inc,san clemente,ca, United States, rox medical inc,san clemente,ca, United States, santa barbara,ca, United States, universitätsklinikum des saarlandes,homburg/saar, Germany, royal college of surgeons in ireland medical school,dublin, Ireland, wales heart research institute,cardiff, United Kingdom, eastbourne district general hospital,east sussex, United Kingdom, connolly hospital,dublin, Ireland, universitatsmedizin berlin,berlin, Germany, universitatsklinikum gieen und marburg gmbh,marburg, Germany, east sussex healthcare nhs trust,east sussex, United Kingdom, royal brompton hospital,london,united kingdom,st helier hospital,surrey, United Kingdom, royal brompton hospital,london,united kingdom,st helier hospital,surrey, United Kingdom, el-zbieta florczak,institute of cardiology,warsaw, Poland, el-zbieta florczak,institute of cardiology,warsaw, Poland, el-zbieta florczak,institute of cardiology,warsaw, Poland, el-zbieta florczak,institute of cardiology,warsaw, Poland, mater private hospital,dublin, Ireland, universitair ziekenhuis brussel,brussels, Belgium, hippokration general hospital of athens,athens, Greece, hippokration general hospital of athens,athens, Greece, st antonius ziekenhuis,nieuwegein, Netherlands, znacardio middelheim,antwerp, Belgium, university of leicester glenfield hospital,nihr leicester cardiovascular biomedical research,leicester, United Kingdom
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved